BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 7, 2017
View Archived Issues
Heptares gives details on discovery of muscarinic M1 receptor agonist HTL-9936
Read More
Phase III results presented for anacetrapib in patients with atherosclerotic vascular disease
Read More
U.K. agency backs Themis Bioscience's Chikungunya vaccine
Read More
TC BioPharm enters CAR-T agreement with UCL
Read More
FDA gives fast track status to NeuroRx's regimen for ASIB in bipolar depression
Read More
FDA approves new formulation of Tracleer for pediatric PAH
Read More
Novel class of selective PI3Kalpha inhibitors from Genentech tested in vivo
Read More
AbbVie submits NDA in U.S. for elagolix
Read More
Catalyst Biosciences reports initial data from phase I/II study of CB-2679d in hemophilia B
Read More
JDFR supports development of vTv Therapeutics' TTP-399 for type 1 diabetes
Read More
Crinetics Pharmaceuticals receives two grants from NIDDK
Read More
Palatin Technologies enters bremelanotide licensing agreement with Fosun Pharma
Read More
Merck & Co. set to acquire Rigontec
Read More
P2Y purinoceptor 6 identified as a target for treating obesity
Read More
Morphotek, Johns Hopkins to collaborate on therapies targeting MASAs
Read More
Bayer seeks EMA marketing approval for BAY-94-9027 for hemophilia A
Read More
Verastem reports phase III topline data on duvelisib in CLL/SLL, expands program into PTCL
Read More
BMS-986144 presented as a promising anti-HCV treatment
Read More
CSIR patents silicon-based cyclic antiparasitics
Read More
Zealand Pharma and Orbit Discovery form multi-target research collaboration
Read More
Shanghai Institute Materia Medica discovers new AMP-activated protein kinase activators
Read More
Novartis initiates phase III trial of ABL-001 in chronic phase CML
Read More
Novel phosphodiesterase PDE4B/A/C inhibitors identified at Pfizer
Read More
EMA grants orphan drug designation to Vivus' tacrolimus for PAH
Read More
Daiichi Sankyo and Sanford Burnham Prebys begin clinical trial of DS-1211
Read More
VIB, Universiteit Ghent and Orionis Biosciences divulge PD-L1-targeting fusion proteins
Read More
Lilly presents novel RANKL-targeting fusion proteins
Read More
FDA places partial clinical hold on Opdivo combination trials in multiple myeloma
Read More
Evotec and Abivax partner to discover and develop novel antiviral agents
Read More